Tyra Biosciences, Inc. financial statements
Tyra Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 119.95M | 10-K |
| Cash and equivalents | USD 77.39M | 10-Q |
| Total debt | USD 5.81M | EODHD |
Tyra Biosciences, Inc. financials on 6ix · Tyra Biosciences, Inc. on 6ix